Evidence map›Paper›PMID 31152601›Full record

ArticleMedical physics2019

A tissue preparation to characterize uterine fibroid tissue properties for thermal therapies.

Christopher Dillon, Maryam Rezvani, Hailey McLean, Marisa Adelman, Mark Dassel, Elke Jarboe, Margit Janát-Amsbury, Allison Payne

Open access · greenAbstract read
In one paragraph

Article in Medical physics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Christopher DillonDepartment of Radiology and Imaging Sciences, University of Utah, Salt Lake City, UT, 84132, USA.
Maryam RezvaniDepartment of Radiology and Imaging Sciences, University of Utah, Salt Lake City, UT, 84132, USA.
Hailey McLeanDepartment of Radiology and Imaging Sciences, University of Utah, Salt Lake City, UT, 84132, USA.
Marisa AdelmanDepartment of Obstetrics and Gynecology, University of Utah, Salt Lake City, UT, 84132, USA.
Mark DasselDepartment of Obstetrics and Gynecology, University of Utah, Salt Lake City, UT, 84132, USA.
Elke JarboeDepartment of Obstetrics and Gynecology, University of Utah, Salt Lake City, UT, 84132, USA.
Margit Janát-AmsburyDepartment of Obstetrics and Gynecology, University of Utah, Salt Lake City, UT, 84132, USA.
Allison PayneDepartment of Radiology and Imaging Sciences, University of Utah, Salt Lake City, UT, 84132, USA.
University of Utah · US

Funding

Siemens MAGNETOM Prisma 3T MRI scannerS10OD018482 · OD · UNIVERSITY OF UTAH · PI PARKER, DENNIS L · 2015 to 2015
$1.2M
The role of T2 and blood flow properties in MRgFUS treatments of uterine fibroidsF32HD085685 · NICHD · UNIVERSITY OF UTAH · PI DILLON, CHRISTOPHER R · 2015 to 2017
$137k
NICHD NIH HHS F32 HD085685NIH HHS F32HD085685NIH HHS S10 OD018482NIH HHS S10OD018482University of Utah
6 · The paper itself

Abstract

purposeTreating uterine fibroids with less invasive therapies such as magnetic resonance-guided focused ultrasound (MRgFUS) is an attractive alternative to surgery. Treatment planning can improve MRgFUS procedures and reduce treatment times, but the tissue properties that currently inform treatment planning tools are not adequate. This study aims to develop an ex vivo uterine fibroid model that can emulate the in vivo environment allowing for characterization of the uterus and fibroid MR, acoustic, and thermal tissue properties while maintaining viability for the necessary postsurgical histopathological assessments.

methodsWomen undergoing a hysterectomy due to fibroid-related symptoms were invited to undergo a preoperative pelvic MRI and to permit postoperative testing of their uterine specimen. Patients that declined or could not be scheduled for a pre-operative MRI were still able to allow post-operative testing of their excised tissue. Following surgical removal of the uterus, nonmorcellated tissues were reperfused with a Krebs-Henseleit buffer solution. An MR-compatible perfusion system was designed to maintain tissue viability inside the MR suite during scanning. MR imaging protocols utilized preoperatively were repeated on whole sample, reperfused ex vivo uterus specimens. Thermal properties including thermal diffusivity and thermal conductivity of the uterus and fibroids were determined using an invasive needle sensor device in 50% of the specimens. Acoustic property measurements (density, speed of sound and attenuation) were obtained for approximately 20% of the tissue samples using both through-transmission and radiation force balance techniques. Differences between fibroid and uterus and in vivo and ex vivo measurements were evaluated with a two-tailed Student t test.

resultsFourteen patients participated in the study and measurements were obtained from 22 unique fibroids. Of the 16 fibroids available for preoperative MRI testing, 69% demonstrated classic hypo-intensity relative to the myometrium, with the remainder presenting with iso- (25%) or hyper-intensity (6%). While thermal diffusivity was not significantly different between fibroid and myometrium tissues (0.217 ± 0.047 and 0.204 ± 0.039 mm

conclusionsThis study developed an MR-compatible extracorporeal perfusion technique that effectively maintains tissue viability, allowing for the direct measurement of patient-specific MR, thermal, and acoustic property values for both fibroid and myometrium tissues. These measured tissue property values will enable further development and validation of treatment planning models that can be utilized during MRgFUS uterine fibroid treatments.

Indexed as

High-Intensity Focused Ultrasound AblationMagnetic Resonance ImagingSurgery, Computer-AssistedFemaleHumansHysterectomyLeiomyomaTissue SurvivalUterusfocused ultrasoundmagnetic resonance imagingtissue propertiesuterine fibroids

Identifiers

PMID31152601
PMCPMC6692230
OpenAlexW2947242320

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.